-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, China Biotech Service (08037.HK) issued an announcement on matters relating to the sale of all issued share capital of Standard Pathology Laboratory Co., Ltd. and Zhuoji Healthcare Co., Ltd. All the prerequisites contained in the sale agreement have been fulfilled, and the sale was completed on August 13, 2026 in accordance with the terms and conditions of the sale agreement. Immediately after completion and on the date of this announcement, Standard Pathology Laboratory and Zhuoji Health will each cease to be a subsidiary of the Group, and the financial results of Standard Pathology Laboratory and Zhuoji Healthcare will no longer be incorporated into the Group's financial results.

Zhitongcaijing·08/13/2026 13:49:11
Listen to the news
Zhitong Finance App News, China Biotech Service (08037.HK) issued an announcement on matters relating to the sale of all issued share capital of Standard Pathology Laboratory Co., Ltd. and Zhuoji Healthcare Co., Ltd. All the prerequisites contained in the sale agreement have been fulfilled, and the sale was completed on August 13, 2026 in accordance with the terms and conditions of the sale agreement. Immediately after completion and on the date of this announcement, Standard Pathology Laboratory and Zhuoji Health will each cease to be a subsidiary of the Group, and the financial results of Standard Pathology Laboratory and Zhuoji Healthcare will no longer be incorporated into the Group's financial results.